Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Abstract EN

(1) Background.

Non-small cell lung cancer (NSCLC) has a high mortality rate.

MiRNAs have been found to be diagnostic biomarkers for NSCLC.

However, controversial results exist.

We conducted this meta-analysis to evaluate the diagnostic value of miRNAs for NSCLC.

(2) Methods.

Databases and reference lists were searched.

Pooled sensitivity (SEN), specificity (SPE), and area under the curve (AUC) were applied to examine the general diagnostic efficacy, and subgroup analysis was also performed.

(3) Results.

Pooled SEN, SPE, and AUC were 85%, 88%, and 0.93, respectively, for 71 studies.

Multiple miRNAs (AUC: 0.96) obtained higher diagnostic value than single miRNA (AUC: 0.86), and the same result was found for Caucasian population (AUC: 0.97) when compared with Asian (AUC: 0.91) and Caucasian/African population (AUC: 0.92).

MiRNA had higher diagnostic efficacy when participants contained both smokers and nonsmokers (AUC is 0.95 for imbalanced group and 0.91 for balanced group) than when containing only smokers (AUC: 0.90).

Meanwhile, AUC was 0.91 for both miR-21 and miR-210.

(4) Conclusions.

Multiple miRNAs such as miR-21 and miR-210 could be used as diagnostic tools for NSCLC, especially for the Caucasian and nonsmoking NSCLC.